Skip to content

GeneDx Holdings WGS Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$442.68M+3.5%$427.54M+6.3%$402.19M+11.0%$362.32M+9.7%$330.14M+8.1%
$134.77M+4.2%$129.37M+6.0%$122.08M+2.7%$118.91M+3.7%$114.68M+3.3%
$307.91M+3.3%$298.17M+6.4%$280.11M+15.1%$243.41M+13.0%$215.46M+10.8%
69.6%-0.2pp69.7%+0.1pp69.6%+2.5pp67.2%+1.9pp65.3%+1.6pp
$79.25M+10.0%$72.03M+21.9%$59.07M+16.0%$50.91M+8.9%$46.73M+2.2%
-$2.62M-3.0%-$2.54M+6.6%-$2.72M+9.4%-$3M+2.5%-$3.08M-1.4%
-$11.48M-42.4%-$8.06M-8.1%-$7.46M-91.3%-$3.9M+83.9%-$24.29M+17.4%
-$77.81M-270%-$21.02M
-17.6%-12.7pp-4.9%
-$39.64M-426%$12.15M
-9%-11.8pp2.8%
-$66M-405%-$13.08M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are GeneDx Holdings's profit margins?
Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
Where does GeneDx Holdings's income statement data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.